Skip to search formSkip to main contentSkip to account menu

Golotimod

Known as: (2R)-2-Amino-5-(((1S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic Acid, Gamma-D-Glutamyl-L-Tryptophan, gamma-D-Glu-L-trp 
An orally bioavailable synthetic peptide containing the amino acids D-glutamine and L-tryptophan connected by a gamma-glutamyl linkage with potential… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Dipeptides

Narrower (1)

SCV-07

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Dynamics of the nasal secretion of cytokines under local application of immunomodulator gamma-D-glutamyl-L-tryptophan (Bestim) to the nasal mucosa in infants and preschool children with tonsillar…
E.V. Shabaldina , A.V. Shabaldin 1, , V.A. Mikhaylenko , A.A. Kolobov , S.V. Ryazantsev , A.S. Simbirtsev 5 1 Kemerovo State… 
2011
2011
Identification of signaling pathways involved in the mechanism of action of the immunomodulatory peptide gamma-D-glutamyl-L-tryptophan.
5591 Background: Gamma-D-glutamyl-L-tryptophan (SCV-07) is being studied for attenuation of oral mucositis (OM) in head and neck… 
2010
2010
Safety and efficacy of gamma-D-glutamyl-L-tryptophan as an intervention for oral mucositis in patients receiving chemoradiation for the treatment of cancers of the head and neck (HNC): Phase II trial…
2008
2008
Golotimod shows encouraging antiviral activity in HCV
  • 2008
  • Corpus ID: 195105771
2004
2004
Development of an efficient enzymatic production of gamma-D-glutamyl-L-tryptophan (SCV-07), a prospective medicine for tuberculosis, with bacterial gamma-glutamyltranspeptidase.
Gamma-D-Glutamyl-L-tryptophan (SCV-07) is a prospective medicine for the treatment of tuberculosis, according to the phase two… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)